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ABSTRACT 
Objective: Simple, sensitive, precise, reproducible and validated visible spectrophotometric methods have been developed for the determination of 
an antimuscarinic drug, namely oxybutynin hydrochloride (OXB) in pure form and in pharmaceutical preparations.  
Methods: Two spectrophotometric methods are based on the formation of yellow colored ion-pair complexes between the studied drug, and two 
sulphonphthalein acid dyes, bromocresol purple (BCP) and bromophenol blue (BPB) with absorption maxima at 410 and 416 nm, respectively.  
Results: The stoichiometric ratio of the formed ion-pair complexes was found to be 1:1 (drug: reagent) for both methods as deduced by Job's 
method of continuous variation. Several parameters such as pH, buffer type, and reagent volume, sequence of addition and effect of extracting 
solvent were optimized to achieve high sensitivity, stability, low blank reading and reproducible results. Under the optimum reaction conditions, 
linear relationships with good correlation coefficients (0.9996-0.9999) were found between the absorbance's and the concentrations of oxybutynin 
over the concentration ranges of 1.0–8.0 μg ml
Faculty of Public Health and Health Informatics, 
Umm AL-Qura University, Makkah, Saudi Arabia 
Email: aymangouda77@gmail.com    
-1 and 1.0–12 μg ml-1 with LOD of 0.21 and 0.19 μg ml-1
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, using BCP and BPB methods, respectively. 
Various analytical parameters have been evaluated and the results have been validated by statistical data.  
Conclusion: The proposed methods were validated in accordance with ICH guidelines and successfully applied to the analysis of pharmaceutical 
formulation. Statistical comparison of the results obtained by applying the proposed methods with those of the reference method revealed good 
agreement and proved that there was no significant difference in the accuracy and precision between the results.  
 
INTRODUCTION 
Oxybutynin hydrochloride is chemically designated as 4-
(diethylamino) -2-butynyl (RS)-2-cyclohexyl-2-hydroxy-2-phenyl 
acetate hydrochloride (fig. 1) [1]. It is an antimuscarinic drug with a 
great selection for the muscarinic receptors of the bladder. It is used 
in the management of urinary frequency, urgency, and incontinence 
in detrusor instability and in the treatment of nocturnal enuresis [2].  
 
 
Fig. 1: The chemical structure of oxybutynin hydrochloride (OXB) 
 
The literature survey revealed that few methods have been 
performed for the determination of OXB such as spectrophotometry 
[3-9], spectrofluorimetry [5], electrochemical methods [10, 11], 
HPTLC [9, 12] and HPLC [8, 13-16]. Most of the reported methods 
(except spectrophotometric methods) are either not appropriately 
sensitive or tedious and utilized expensive instruments that are not 
available in most quality control laboratories and the procedures are 
not simple to perform. 
Visible spectrophotometric methods represent the most convenient 
analytical technique in most quality control laboratories because of 
their selectivity. In addition, they are easier, less expensive and less 
time consuming compared with many other methods. The reported 
methods for OXB in spite of being spectrophotometric method, but 
they lack the simplicity which is found usually in this technique 
(table 1). The analytically important functional groups of OXB were 
not properly exploited for designing suitable spectrophotometric 
methods for the determination of OXB. Hence a new sensitive and 
flexible visible spectrophotometric method was developed based on 
the reactivity of OXB with two acid dye reagents such as BCP and 
BPB because of the presence of the aliphatic tertiary amino group 
(the basic group) in OXB.  
Therefore the aim of this work is to develop a simple, sensitive, 
accurate, precise, low-cost and validated two spectrophotometric 
methods for the determination of oxybutynin hydrochloride (OXB) 
in pure form and in pharmaceutical formulations with no need for 
any expensive or sophisticated instruments. The proposed methods 
are based on the ability of OXB to form stable ion-pair complexes 
with BCP and BPB. 
MATERIALS AND METHODS 
Apparatus 
All absorption spectra were made using Kontron Unikon 930 (UV-
Visible) spectrophotometer (German) with a scanning speed of 200 
nm min-1 and a band width of 2.0 nm, equipped with 10 mm 
matched quartz cells. The pH values of different buffer solutions 
were checked using a Hanna pH-meter instrument (pH 211) 
(Romania) equipped with a combined glass-calomel electrode. 
Materials and reagents 
All reagents and chemicals used were of analytical or 
pharmaceutical grade and all solutions were prepared fresh daily. 
Materials-Pure sample of oxybutynin hydrochloride (OXB) was 
kindly supplied by the Egyptian Company for Chemicals and 
Pharmaceuticals (ADWIA) (10th of Ramadan City, Egypt), with a 
purity of 99.84±0.40% by applying the official method [1].  
Pharmaceutical formulations 
The following tablets containing the drug were purchased from local 
pharmacies. 
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-Ditronin® tablets, batch # 4034003, labeled to contain 5.0 mg OXB 
per tablet, product of Pharaonia Pharmaceuticals Company 
(Alexandria, Egypt). 
-Uripan® tablets, batch # 140576, labeled to contain 5.0 mg OXB 
per tablet, product of ADWIA Co. S. A. E, 10th
Table 1: Comparison between the reported methods for spectrophotometric determination of OXB 
 of Ramadan City, 
Egypt. 
  













Tropaoline OOO (TPOOO) 480 1.0-7.5 1.954 x 10 0.062 4 [3] 
 Alizarin red S (ARS) 430 2.0-15 1.545 x 10 0.11 4 
2,3-dichloro-5,6-dicayno-p-benzoquinone (DDQ) 457 20-80 - 0.205 [4] 
2,5-dichloro-3,6-dihydroxy-p-benzoquinone (p-CLA) 520 30-160 - 0.524 
Malonic acid anhydride in acetic acid anhydride 375 4.0–40 - 1.12 [5] 
Bromothymol blue (BTB) 414 2.5-12.5 0.0579 - [6] 
Fe(III)/phenanthroline mixture 510 0.8-4.8 - - [7] 
Picric acid 344 - - - [8] 
Bromocresol purple (BCP) 410 1.0-8.0 2.34 x 104 0.21   Proposed work 
Bromophenol blue (BPB) 416 1.0-12 1.22 x 104 0.19   
 
Preparation of stock standard solution 
A stock standard solution (100 µg ml-1) and (1.0 × 10−3 mol l-1) of 
OXB were prepared by dissolving 10 and 39 mg of pure drug in 10 
ml of ethanol in a 100 ml volumetric flask and completed to 100 ml 
with bidistilled water. This solution was stable for at least 7.0 days 
when kept in the refrigerator. Serial dilution with the same solvent 
was performed to obtain the appropriate concentration range 
Reagents 
All reagents and solvents used were of analytical-reagent grade. 
Bromocresol purple (BCP) and bromophenol blue (BPB) (BDH 
Chemicals LTD, Poole, England) and used without further 
purification. Stock solutions (1.0×10−3 mol l-1) of reagents were 
prepared by dissolving the appropriate weight of each dye in 5.0 ml 
of ethanol (96%) and diluted to 100 ml in a calibrated flask with 
bidistilled water. These solutions were kept in the refrigerator. 
Series of buffer solutions of KCl–HCl (pH=1.0-2.2), NaOAc–HCl 
(pH=1.99-4.92), NaOAc–AcOH (pH=3.4-5.6) and potassium hydrogen 
phthalate–HCl (pH=2.0-7.0) were prepared by following the 
standard methods [17]. The pH of each solution was adjusted to an 
appropriate value by the addition of 0.2 mol l-1 hydrochloric acid or 
sodium hydroxide with the help of the pH meter. Freshly prepared 
solutions were always employed. Chloroform and methylene 
chloride (BDH), anhydrous sodium sulfate (Prolabo), ethanol (BDH). 
General recommended procedure  
Accurately measured aliquots (0.1–1.2 ml) the of OXB (100 µg ml-1) 
were transferred into 10 ml measuring flasks. A volume of 2.0 ml of 
1.0×10-3 mol l-1
Twenty tablets were finely pulverized and weighed. A weighed 
quantity of the powdered tablets equivalent to 10 mg of OXB was 
transferred into a 100 ml volumetric flask, about 20 ml of ethanol 
was added and the flask was sonicated for 30 min. The volume was 
completed to the mark with bidistilled water, mixed well and 
filtered. Aliquots containing the drug in the final concentration 
ranges 1.0-8.0 and 1.0–12 μg ml
 BCP or BPB was added. Then, 2.0 ml acetate buffers 
at the optimum pH 3.0 and 3.5 using BCP and BPB, respectively and 
the volume was completed to 10 ml with distilled water. The ion-
pairs were extracted with 10 ml of dichloromethane by shaking for 
2.0 min, and then the combined dichloromethane extracts were 
dried over anhydrous sodium sulfate. The absorbance of the yellow 
colored ion-pair complexes were measured at 410 and 416 nm, 
using BCP and BPB, respectively, within 20 min of extraction against 
the reagent blank similarly prepared in the same manner except an 
addition of drugs. All measurements were made at room 
temperature (25±2 °C). In both the methods, a standard curve was 
prepared by plotting the increasing absorbance values versus 
concentrations of drug. A linear equation for the standard curve was 
calculated by linear regression. 
Procedure for commercial tablets 
-1 for BCP and BPB methods, 
respectively were analyzed as described under “Construction of the 
Calibration Graph”. The concentration of the drug was determined 
either from the calibration curve or using the corresponding 
regression equation. 
Stoichiometric relationship  
The stoichiometric ratios of the ion-pairs formed between OXB and 
the reagents were determined by applying the continuous variation 
[18] and the molar ratio [19] methods at the optimum wavelengths. 
In continuous variation method, equimolar solutions were 
employed: a 1.0 x 10-3 mol l-1 standard solution of drug and 1.0 x 10-3 
mol l-1 solution of dye was used. A series of solutions was prepared 
in which the total volume of the studied drugs and the dye was kept 
at 2.0 ml. The drug and reagent were mixed in various 
complementary proportions (0.2:1.8, 0.4:1.6, 0.6:1.4, 0.8:1.2, 1.0:1.0, 
1.2:0.8, 1.4:0.6, 1.6:0.4, 1.8:0.2) and completed to volume in a 10 ml 
calibrated flask with the appropriate solvent for extraction following 
the above mentioned procedure. In the molar ratio method, the 
concentration of OXB was kept constant 1.0 ml of (1.0 x10-3 mol l-1) 
while that of dyes (1.0 x10-3 mol l-1
It was observed that the effective extraction of the complex depends 
on the type of the buffer used and its pH. The effect of pH was 
) is regularly varied (0.2–2.4 ml). 
The absorbance of the prepared solutions measured at optimum 
condition and at the optimum wavelength for each complex. 
RESULTS AND DISCUSSION 
Absorption spectra 
The proposed methods are based on the reactivity of tertiary amine 
group of OXB with two acid dyes (BCP and BPB). The nitrogenous 
drugs are present in positively charged protonated forms and 
anionic dyes of sulphonpthalein group present mainly in anionic 
form at a pH ≥ 3.0. So when treated with an acid dye at pH range 
(2.8-5.0) of acidic buffer solutions, a yellow ion-pair complex which 
is extracted with organic solvent is formed. The absorption spectra 
of the yellow ion-pair complexes of OXB-BCP and BPB), which were 
formed between OXB and BCP or BPB reagents and show maximum 
absorbance's at 41o and 416 nm, respectively against the blank 
solution. 
Optimization of the reaction conditions  
A number of preliminary experiments established optimum 
conditions necessary for rapid and quantitative formation of colored 
ion-paired complexes achieve the maximum stability and sensitivity. 
Optimum condition was fixed by varying one parameter at a time 
while keeping other parameter constant and observing its effect on 
the absorbance. 
Effects of buffer type and pH  
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studied by extracting the colored complexes in the presence of 
various buffers such as KCl–HCl (pH 1.0-2.2), NaOAc–HCl (pH 1.99-
4.92) and NaOAc–AcOH (pH 3.6-5.6). It is evident that the maximum 
color intensity and maximum absorbance were found in NaOAc_HCl 
buffer. It is evident that the absorbance of the ion pair complex was 
maximal at pH 3.5 and 3.0 for BCP and BPB methods, respectively 
(fig. 2). Buffer volume was determined by applying the same 
experiment and variation the volume regularly (0.5-4.0 ml). The 
higher absorbance value and reproducible results were obtained by 






















Fig. 2: Effect of pH of buffer solution on ion pair complex 
formation between (8.0 μg ml-1) OXB and (1.0 x 10-3 mol l-1
The OXB concentration was kept constant, while the concentrations 
of BCP or BPB was varied from 0.5–4.0 ml of 1.0×10-3 mol l-1. The 
results showed that the absorbance of the extracted ion-pairs 
increased by increasing the BCP or BPB concentrations till 2.0 ml. 
After this volume, the absorbance remains constant by increasing 
the volume of the reagents (fig. 3). So an excess of reagents has no 
effect on the determination of the drug.  
) BCP 
and BPB reagents 
 
Effect of reagent concentration  
Choice of extracting solvent  
Different organic solvents as dichloromethane, carbon tetrachloride, 
chloroform and ether were tested as extractive solvents for the 
proposed method. Dichloromethane was preferred to other solvents 
for its selective and obtained the highest absorbance with 
dichloromethane. It was also observed that only one extraction with 
total volume 10 ml solvent was adequate to achieve a quantitative 
recovery of the complexes, maximum absorbance intensity and 
considerably lower extraction ability for the reagent blank and the 
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Fig. 3: Effect of volume of (1.0 ×10−3 mol l-1) BCP and BPB reagent 
on the ion pair complex formation with (8.0 μg ml-1) OXB 
 
Effect of shaking time and temperature 
The optimum shaking time was investigated by shaking from 0.5-
5.0 min. Maximum and constant absorbance value were obtained 
when extracted after 1.5 min shaking. Therefore, shaking time of 2.0 
min was maintained throughout the experiment. The effect of 
temperature on colored complexes was studied by measuring the 
absorbance values over the temperature range 20-35 °C. It was 
found that the absorbance of the colored ion pair complex was 
constantly up to 30 °C. At higher temperatures, the drug 
concentration was found to increase due to the volatile nature of the 
dichloromethane. Therefore, the temperature chosen was room 
temperature (25±2 °C) as the best temperature for micro-
determination of OXB in pure and pharmaceutical formulations. The 
absorbance of both complexes remains stable for at least 12 h at 
room temperature. 
Composition of the ion-pair complexes 
The molar ratio between OXB and BCP or BPB in the ion-pair 
complexes was determined by Job’s method of continuous variation. 
Job’s method of continuous variation of equimolar solutions was 
employed: a 1.0 × 10−3 mol l-1 standard solution of drug base and 
1.0 × 10−3 mol l-1 solution of BCP or BPB were used. A series solution 
was prepared in which the total volume of drug and reagent was 
kept at 2.0 ml in the total volume of 10 ml of the aqueous layer. The 
absorbance of extracting an ion-pair in each instance was measured 
at the optimum wavelength and plotted against the mole fraction of 
the drug. The results indicate that the molar ratio of (drug: dye) is 
(1:1) complex was formed through the electrostatic attraction 
between the positive charged OXB+ions and negatively charged dye, 
D− ions (fig. 4). The extraction equilibrium can be represented as 
follows:  
D(aq) (aq) (org)OXB(aq) OXB OXB D  D  
Where OXB+andD− represent the protonated drug and the anion of 
the dye (BCP− or BPB−), respectively, and the subscript (aq) and 
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Fig. 4: Job’s method of continuous variation graph for the reaction 
of OXB with the studied dyes, [drug] = [dye] = (1.0×10−3 mol l-1) 
 
Method of validation 
Linearity 
At described experimental conditions for OXB determination, standard 
calibration curves with reagents were constructed by plotting 
absorbance vs. concentration of OXB. The statistical parameters were 
given in the regression equations calculated from the calibration 
graphs A = aC+b, where A is the absorbance and C is concentration in 
μg ml-1. The linearity of calibration graphs was proved by the high 
values of the correlation coefficient (r) and the small values of the y-
intercepts of the regression equations. The apparent molar 
absorptivity of the resulting colored ion-pair complexes and relative 
standard deviation of response factors for each proposed 
spectrophotometric method were also calculated and recorded in table 
2. The molar absorptivity of BCP>BPB ion-pair complexes. 
Sensitivity 
The limits of detection (LOD) and quantitation (LOQ) for the proposed 
methods were calculated using the following equation [20, 21]:  
LOD = 3s/k and LOQ = 10 s/k 
Where s the standard deviation of the response of the blank or the 
standard deviation of intercepts of regression lines and k is the 
sensitivity, namely the slope of the calibration graph. In accordance 
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with the formula, the limit of detection was found to be 0.21 and 
0.19 µg mL−1 for BCP and BPB methods, respectively.  
According to this equation, the limit of quantitation was found to 
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Fig. 4: Calibration curves for determination of OXB (1.0–8.0 μg ml-1) using BCP and (1.0–12 μg ml-1) using BPB 
 
Table 2: Statistical analysis of calibration graphs and analytical data in the determination of OXB using the proposed methods 
Parameters BCP BPB 
Wavelengths λ max (nm) 410 416 
Beer’s law limits (µg ml−1) 1.0-8.0 1.0-12 
Molar absorptivity ε, (l mol-1 cm-1) x 104 2.34 1.22 
Sandell,s sensitivity (ng cm-2) 16.84 32.41 
Regression equation a    
Intercept (a) 0.0033 -0.0009 
Standard deviation of intercept (Sa) 0.0064 0.0027 
Slope (b) 0.0584 0.032 
Standard deviation of slope (Sb) 0.001 0.002 
Correlation coefficient (r) 0.9999 0.9994 
LOD (µg ml−1)b 0.18 0.24 
LOQ (µg ml−1)b 0.60 0.80 
mean±SD 99.63±0.57 99.76±0.88 
RSD% 0.57 0.88 
RE% 0.60 0.92 
t-test c  0.67 0.19 
F-testc 2.03 4.84 
aA = a+bC, where C is the concentration in µg mL−1, A is the absorbance units, bLOD, limit of detection; LOQ, limit of quantification; ε,molar 
absorptivity, cThe theoretical values of t and F at P= 0.05 are 2.571 and 5.05, respectively. 
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Accuracy and precision  
Specificity of ion-pair reaction and selective determination of OXB 
which was the basic nitrogenous compound with acid dyes could be 
possible. Percentage relative standard deviation (RSD %) as 
precision and percentage relative error (RE %) as accuracy of the 
suggested methods was calculated. Precision was carried out by six 
determinations at three different concentrations in these 
spectrophotometric methods. The percentage relative error 
calculated using the following equation:  
RE % = [(founded–added)/added] x 100 
The inter-day and intra-day precision and accuracy results are shown in 
(table 3). These results of accuracy and precision show that the proposed 
methods have good repeatability and reproducibility. 
 
Table 3: Intra-day and Inter-day precision and accuracy data for OXB obtained by the proposed methods 



















BCP 2.0 99.10 0.43 -0.90 1.982± 
0.009 
100.50 0.50 -0.50 2.01± 
0.011 
6.0 99.60 0.72 -0.40 5.976± 
0.045 
99.50 0.80 -0.50 5.97± 
0.05 
8.0 100.50 1.30 0.50 8.04± 
0.11 
100.70 1.60 0.70 8.056±0.135 
BPB 2.0 99.70 0.65 -0.30 1.994± 
0.014 
99.00 0.48 -1.0 1.98± 
0.01 
6.0 101.00 0.90 1.0 6.06± 
0.057 
99.20 0.75 -0.80 5.952± 
0.047 
10 99.00 1.50 -1.0 9.90± 
0.156 
101.00 1.25 1.0 10.10± 
0.133 
aMean of six determination, RSD%, percentage relative standard deviation; RE%, percentage relative error, bConfidence limit at 95% confidence 
level and five degrees of freedom (t = 2.571). 
 
Table 4: Method robustness and ruggedness expressed as intermediate precision (RSD %) for OXB-BCP ion pair complex 
OXB taken  
(μg mL-1) 
Robustness Ruggedness 
Parameters altered Inter-analysts Inter-instruments 
Volume of BCP a Volume of buffer b Reaction time c (RSD/%) (N=3) (RSD/%) (N=3) 
2.0 1.48 1.10 1.0 1.35 1.20 
4.0 1.70 1.20 1.40 1.10 1.90 
8.0 1.90 1.80 1.60 2.0 1.65 
aThe volumes of BCP dye used were 2.0±0.2 ml, bThe volumes of buffer used were 2.0±0.2 ml, cThe reaction times were 2.0±0.5 min. 
 
Table 5: Application of the standard addition technique for the determination of OXB in dosage forms using the proposed methods 
Sample Taken 
(μg ml-1) 









Ditronin® tablets 1.0 - 99.40 - 99.10  
 1.0 99.10 2.0 100.50  
 3.0 100.70 5.0 99.00  
 5.0 99.80 7.0 99.20  
 7.0 98.90 9.0 99.10  





R. S. D%   0.715  0.63 0.75 
V   0.507  0.397 0.56 
S. E   0.32  0.282 0.31 
t-valueb   0.54  1.03  
F-valueb   1.10  1.41  
Uripan® tablets 1.0 - 99.10 - 99.30  
  1.0 100.20 2.0 99.80  
  3.0 99.80 5.0 98.60  
  5.0 98.90 7.0 100.40  
  7.0 100.60 9.0 99.00  





R. S. D%   0.72  0.791 0.665 
V   0.517  0.633 0.445 
S. E   0.32  0.356 0.274 
t-valueb   1.05  0.215  
F-valueb   1.16  1.42  
aAverage of six determinations, bThe theoretical values of t and F are 2.571 and 5.05, respectively at confidence limit at 95% confidence level and 
five degrees of freedom (p= 0.05). 
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Robustness and ruggedness 
For the evaluation of the method robustness, some parameters were 
interchanged; pH, dye concentration, wavelength range, and shaking 
time. The capacity remains unaffected by small deliberate variations. 
Method ruggedness was expressed as RSD% of the same procedure 
applied by two analysts and in two different instruments on 
different days. The results showed no statistical differences between 
different analysts and instruments, suggesting that the developed 
methods were robust and rugged (table 4). 
Effects of interference 
To assess the usefulness of the method, the effect of diluents, 
excipients and additives which often accompany OXB in its 
formulations (nasal spray and drops) was studied. The results 
indicated that there is no interference from excipients and additives, 
indicating a high selectivity for determining OXB in its formulations. 
Applications to pharmaceutical formulations  
The proposed methods have been successfully applied to the 
determination of OXB in dosage forms (Ditronin® tablets and 
Uripan® tablets). The results in table 4 showed that the excipients 
in the dosage forms do not interfere. A statistical comparison of the 
results for determination of OXB from the same batch of material by 
the proposed and official method [1] is shown in table 4. The results 
agreed well with the label claim and also are in agreement with the 
results obtained by the reference method. Statistical analysis of the 
results using Student’s t-test for accuracy and F-test for precision 
revealed no significant difference between the proposed and 
reference method at the 95 % confidence level with respect to 
accuracy and precision [21] (table 5). To ascertain the accuracy and 
validity of the proposed methods, recovery experiment was 
performed via standard addition technique. With a fixed and known 
amount of OXB in dosage form (pre-analyzed), pure drug was added 
at different concentrations and the total was found by the proposed 
methods. The results of this study presented in table 4 indicated that 
the commonly added excipients did not interfere with the assay. 
CONCLUSION 
This paper describes the application of extractive ion–pair 
complexation reaction with acid dyes for the quantification of OXB in 
pure form and pharmaceutical formulations. Compared with the 
existing visible spectrophotometric methods, the proposed methods 
have the advantages of relatively simple, rapid, cost-effective, free 
from auxiliary reagents and more sensitive for determining OXB in 
pure form and pharmaceutical formulations. Moreover, the 
proposed methods are free from tedious experimental steps such as 
heating unlike the previously reported spectrophotometric methods 
cited earlier. The most attractive feature of these methods is its 
relative freedom from interference by the usual diluents and 
excipients in amounts far in excess of their normal occurrence in 
pharmaceutical formulations. The statistical parameters and the 
recovery data reveal high precision and accuracy of the methods 
besides being robust and rugged. Therefore, the validated method 
could be useful for routine quality control assay of the studied drug 
in pure form and pharmaceutical formulations. 
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